Uncategorized
Featured Stories
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
Forging the Future of Chronic Care: 3 Ways Tech is Helping Transform the Patient Experience
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Kidney Care Outperforms All Dialysis Providers in Quality Incentive Program
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced its 2014 end stage renal disease (ESRD) Quality…
-
DaVita Names Chief Medical Officer for Saudi Operations
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it has named Dr. Abdulkareem Alsuwaida, FRCPC, MSc, as…
-
DaVita HealthCare Partners Inc. Announces Results as of Consent Payment Deadline and Execution of Supplemental Indenture related to its 6 3/8% Senior Notes due 2018
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced the execution of the supplemental indenture related to its previously announced consent solicitation (the “Consent…
-
DaVita HealthCare Partners Inc. Announces Pricing of $1.75 Billion Senior Notes
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced the pricing of $1.75 billion principal amount of 5.125% Senior Notes due 2024 (the “Senior Notes”). The offering is…
-
DaVita HealthCare Partners Inc. Announces Offering of $1.75 Billion Senior Notes
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced that it intends to offer, subject to market and other conditions, $1.75 billion principal amount of senior notes due…
